- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
McKesson debuts IT management tool
McKesson this week unveiled a new health information management (HIM) tool to centralize and simplify the electronic release of patient records.
McKesson debuts IT management tool
McKesson this week unveiled a new health information management (HIM) tool to centralize and simplify the electronic release of patient records. The company’s Horizon Patient Folder Release of Information, currently in beta trials but shown at the American Health Information Management Association (AHIMA) convention, is designed to help hospitals and medical practices increase efficiency and generate revenue. The software automates many of the manual steps associated with the release of patient information. As a result, medical administrators are able to manage the release of information themselves or significantly streamline their current process, creating the opportunity to generate new revenue streams, according to McKesson.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
